Home  >  Health Check  >  Lambda variant of Sars-Cov-2
Health Check
Lambda variant of Sars-Cov-2
Health Check
Jul 7, 2021

The lambda variant of coronavirus, first seen in Peru and Chile, has now spread to 27 other countries and new research just out suggests it’s better than other variants at escaping the antibodies produced by the CoronaVac vaccine that’s widely used in Latin America. The WHO does only currently classify it as a variant of interest and not a variant of concern. Ricardo Soto Rifo from the Faculty of Medicine at the University of Chile, Santiago who conducted this new research explains his findings.

A charity in the UK called Ovacome has long run in person support groups for women with ovarian cancer. And now women who live miles apart, but share similar experiences have got to know each other very well, online, during the pandemic. To find out what happens in these meetings, Health Check dropped in, on Zoom, to listen in to Gill, Gillian, Siobhan, Allyson and Jo.

Dr Per Block, a research lecturer at the University of Oxford, has been investigating whether moods are contagious and crucially whether we pick on up good moods or bad moods more easily. The results of his study with teenage members of choirs and orchestras who were away on tour together have just been published in the journal Emotion. He tells Claudia what he found.

Claudia’s studio guest is family doctor, Ann Robinson, who talks about new research into diet and migraines and whether a David Beckham style plastic boot or a traditional plaster cast is the best treatment for a broken ankle.

Presenter: Claudia Hammond Producer: Erika Wright and Paula McGrath

(Picture: A woman receives her first dose of the CoronaVac vaccine during a door-to-door vaccination day against Covid-19 on 03 July 2021 in a rural area of the Jerusalén municipality, Cundinamarca Department, Colombia. Credit: Guillermo Legaria/Getty Images.)

More Episodes

Jun 24, 2026
Lack of evidence most IVF ‘add-ons’ improve fertility

Many people with infertility use in vitro fertilisation (IVF), however the probability of having a baby following IVF is only approximately 30-40% per cycle and decreases significantly with age. It can be a lengthy and expensive process. Providers sometimes offer ‘add-ons’, additional treatments that they claim could help patients conceive, which are themselves also usually expensive. In Australia, New Zealand and the United Kingdom more than 70% of patients pay for at least one of these add-ons. A new review published in The Lancet Obstetrics, Gynaecology, & Women’s Health journal has found that evidence on the benefits of these add-on treatments is unclear. Claudia Hammond speaks to Dr Sarah Lensen, Senior Research Fellow in the Department of Obstetrics, Gynaecology and Newborn Health at the University of Melbourne.

Joining Claudia from Ghana is genito-urinary consultant and HIV expert, Vanessa Apea. Claudia and Vanessa discuss a draft African Charter on Family, Sovereignty and Values, which claims that comprehensive sex education, as well as a range of sexual and reproductive health rights, are a threat to African families from foreign ideologies.

They also discuss a report from the Office of Inspector General of US Agency for International Development (USAID) which reveals that President Donald Trump’s administration has spent hundreds of thousands of dollars in storage and transportation costs for $9.7 million worth of contraceptives that are being stored in Belgium rather than distributed to the various low-income countries they were intended for. Many of the withheld contraceptives are now expired or unusable due to their removal from temperature-controlled storage.

We also hear from Health Check reporter Jane Chambers in the Chilean city of Valdivia, where wetlands are part of everyday life—and increasingly, part of people’s health. And we hear how faecal-microbiome transplants could improve the efficacy of some antidepressants in patients with major depressive disorder.

Presenter: Claudia Hammond Producers: Jonathan Blackwell & Georgia Christie


26min 29sec



Lambda variant of Sars-Cov-2

--:--
--:--